Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
2.45M
-
Shares change
-
-434K
-
Total reported value, excl. options
-
$5.17M
-
Value change
-
-$1.67M
-
Number of buys
-
8
-
Number of sells
-
-13
-
Price
-
$2.11
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q2 2024
31 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q2 2024.
iBio, Inc. - Common Stock (IBIO) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.45M shares
of 22.5M outstanding shares and own 10.91% of the company stock.
Largest 10 shareholders include Ikarian Capital, LLC (600K shares), Lynx1 Capital Management LP (600K shares), ADAR1 Capital Management, LLC (570K shares), Opaleye Management Inc. (375K shares), BOOTHBAY FUND MANAGEMENT, LLC (160K shares), GEODE CAPITAL MANAGEMENT, LLC (49.2K shares), UBS Group AG (40.7K shares), VANGUARD GROUP INC (36K shares), NORTHERN TRUST CORP (10.2K shares), and BlackRock Inc. (5.57K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.